[HTML][HTML] Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents
L Mauri, DJ Kereiakes, RW Yeh… - … England Journal of …, 2014 - Mass Medical Soc
Background Dual antiplatelet therapy is recommended after coronary stenting to prevent
thrombotic complications, yet the benefits and risks of treatment beyond 1 year are …
thrombotic complications, yet the benefits and risks of treatment beyond 1 year are …
Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial
Background—The risks and benefits of long-term dual antiplatelet therapy remain unclear.
Methods and Results—This prospective, multicenter, open-label, randomized comparison …
Methods and Results—This prospective, multicenter, open-label, randomized comparison …
[HTML][HTML] Duration of dual antiplatelet therapy after implantation of drug-eluting stents
Background The potential benefits and risks of the use of dual antiplatelet therapy beyond a
12-month period in patients receiving drug-eluting stents have not been clearly established …
12-month period in patients receiving drug-eluting stents have not been clearly established …
Meta-analysis of randomized clinical trials comparing short-term versus long-term dual antiplatelet therapy following drug-eluting stents
G El-Hayek, F Messerli, S Bangalore, MK Hong… - The American journal of …, 2014 - Elsevier
Current guidelines recommend 12 months of dual antiplatelet therapy (DAPT) after drug-
eluting stent (DES) implantation in the absence of increased bleeding risk. Studies have …
eluting stent (DES) implantation in the absence of increased bleeding risk. Studies have …
6-versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial
M Gilard, P Barragan, AAL Noryani, HA Noor… - Journal of the American …, 2015 - jacc.org
Background: The currently recommended duration of dual antiplatelet therapy (DAPT) in
drug-eluting stent (DES) recipients is 12 months to reduce the risk of late stent thrombosis …
drug-eluting stent (DES) recipients is 12 months to reduce the risk of late stent thrombosis …
1-month dual-antiplatelet therapy followed by aspirin monotherapy after polymer-free drug-coated stent implantation: one-month DAPT trial
Objectives The aim of this study was to determine whether 1 month of dual-antiplatelet
therapy (DAPT) followed by aspirin monotherapy after polymer-free drug-coated stent (PF …
therapy (DAPT) followed by aspirin monotherapy after polymer-free drug-coated stent (PF …
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association …
CL Grines, RO Bonow, DE Casey Jr, TJ Gardner… - Circulation, 2007 - Am Heart Assoc
Dual antiplatelet therapy with aspirin and a thienopyridine has been shown to reduce
cardiac events after coronary stenting. However, many patients and healthcare providers …
cardiac events after coronary stenting. However, many patients and healthcare providers …
Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial
M Valgimigli, G Campo, M Monti, P Vranckx… - Circulation, 2012 - Am Heart Assoc
Background—The optimal duration of dual-antiplatelet therapy and the risk-benefit ratio for
long-term dual-antiplatelet therapy after coronary stenting remain poorly defined. We …
long-term dual-antiplatelet therapy after coronary stenting remain poorly defined. We …
Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 …
L Mauri, DJ Kereiakes, SLT Normand, SD Wiviott… - American heart …, 2010 - Elsevier
BACKGROUND: Dual antiplatelet therapy with aspirin and thienopyridines (clopidogrel or
prasugrel) is required after placement of coronary stents to prevent thrombotic …
prasugrel) is required after placement of coronary stents to prevent thrombotic …
Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials
Background: The optimal duration of dual antiplatelet therapy (DAPT) after drug-eluting stent
(DES) implantation is unclear, and its risks and benefits may vary according to DES …
(DES) implantation is unclear, and its risks and benefits may vary according to DES …